VITILIGO CLINICAL TRIALS
ClinicalTrials.gov A service of the U.S. National Institutes of Health
Studies found for: vitiligo
RESEARCH INSTITUTIONS / CLINICAL TRIALS
What Research Is Being Conducted on Vitiligo?
In the past, research on the role that melanocytes play in vitiligo has greatly increased. Genetic advances have permitted relatively rapid increases in knowledge of melanocytes at the cellular and molecular levels.
Much of the research that holds promise for understanding, treating, and possibly preventing vitiligo is supported by the NIAMS. Researchers are looking at the immune response to see if interrupting certain signals given off by melanocytes can help stop the spread of depigmentation. They are examining the way melanocytes receive signals from other skin cells that direct them to deposit the pigment.
Others are trying to determine the molecular mechanisms involved in creating melanocytes. This understanding may allow researchers to stimulate the creation of melanocytes from stem cells of hair follicles and use them to add pigment back into affected skin. Such a therapy may be more effective and safer than current light therapies.
The NIAMS also supports a large collaborative project looking for genes that may contribute to vitiligo in several ethnic groups. It is hoped that genetic analyses of these groups will enable identification of one or more vitiligo susceptibility genes and the roles the genes play in contributing to the disease. This work may lead to development of specific approaches to disease therapy and prevention for patients at high genetic risk.
More information on research is available from the following resources:
– NIH Clinical Research Trials and You helps people learn more about clinical trials, why they matter, and how to participate. Visitors to the website will find information about the basics of participating in a clinical trial, first-hand stories from actual clinical trial volunteers, explanations from researchers, and links to how to search for a trial or enroll in a research-matching program.
– ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions.
– NIH RePORTER is an electronic tool that allows users to search a repository of both intramural and extramural NIH-funded research projects from the past 25 years and access publications (since 1985) and patents resulting from NIH funding.
– PubMed is a free service of the U.S. National Library of Medicine that lets you search millions of journal citations and abstracts in the fields of medicine, nursing, dentistry, veterinary medicine, the health care system, and preclinical sciences.
Loyolaresearchers engineer protein to combat the skin disorder vitiligo
Vitiligo Clinic and Research Center
My name is John Harris – I am a dermatologist who treats patients with vitiligo and doesresearch on the disease. I have created a webpage to educate patients, and ablog to discuss common questions in vitiligo. This is the site: http://www.umassmed.edu/vitiligo/
Topical JAK inhibitor shown to be effective for facial vitiligo
Vitiligo is important, treatable, and has an exciting future (video)
John E. Harris Md, Phd’s VITILIGO WEBINAR.
On YouTube you can chose English subtitle!
Prof. KARIN U. SCHALLREUTER PC-KUS pseudocatalase cream plus calcium http://www.vitiligo.eu.com/behandlu…
Rendelni nem lehet. Kivizsgáláshoz kötik a kezelést. Vagy Németországba kellkiutazni. Vagy a Holt-tengernél kell részt venni a kezelésen. (A legjobberedményt a Holt-tengeri kezelés és a PC-KUS krém kombinációjával tudják elérni.
THE DEAD SEA RESEARCH CENTER (D.S.R.C.)
National Center for Biotechnology Information
PubMed Commons – NCBI
ARTICLES (SEARCH FOR VITILIGO
Dr Bruce Katz on New Lasertreatment for vitiligo
Modified protein could become first effective treatment for vitiligo skin disorder
Date:February 27, 2013
Source: Loyola University Health System
Researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune responses in human skin tissue samples. The modified protein is potentially the first effective treatment for vitiligo.
SEVERAL DOCTORS, RESEARCHERS, VITILIGO PERSONALITIES:
Research Clinical Trials
Tofacitinib treatment for vitiligo